Technical Analysis for EDIT - Editas Medicine, Inc.

Grade Last Price % Change Price Change
F 40.16 -0.50% -0.20
EDIT closed down 6.42 percent on Thursday, March 4, 2021, on 1.35 times normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical EDIT trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish -0.50%
Multiple of Ten Bullish Other -0.50%
Wide Bands Range Expansion -0.50%
Down 3 Days in a Row Weakness -0.50%
Lower Bollinger Band Touch Weakness -0.50%
Oversold Stochastic Weakness -0.50%
New Downtrend Bearish -6.89%
Wide Bands Range Expansion -6.89%
Oversold Stochastic Weakness -6.89%
Stochastic Buy Signal Bullish -12.10%
Older End-of-Day Signals for EDIT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 10% about 3 hours ago
Lower Bollinger Band Support about 4 hours ago
Fell Below Previous Day's Low about 4 hours ago
60 Minute Opening Range Breakdown about 4 hours ago
Down 5% about 4 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Immune System Enzymes Genetic Engineering Genome CRISPR Genome Editing Cas9

Is EDIT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 99.95
52 Week Low 14.01
Average Volume 3,055,417
200-Day Moving Average 41.10
50-Day Moving Average 65.50
20-Day Moving Average 53.94
10-Day Moving Average 47.24
Average True Range 5.06
ADX 26.82
+DI 14.04
-DI 39.82
Chandelier Exit (Long, 3 ATRs ) 55.22
Chandelier Exit (Short, 3 ATRs ) 52.80
Upper Bollinger Band 70.21
Lower Bollinger Band 37.66
Percent B (%b) 0.08
BandWidth 60.35
MACD Line -5.83
MACD Signal Line -4.72
MACD Histogram -1.1076
Fundamentals Value
Market Cap 2.52 Billion
Num Shares 62.3 Million
EPS -2.14
Price-to-Earnings (P/E) Ratio -18.88
Price-to-Sales 20.35
Price-to-Book 4.70
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 48.93
Resistance 3 (R3) 48.97 46.15 47.50
Resistance 2 (R2) 46.15 43.97 46.13 47.02
Resistance 1 (R1) 43.26 42.62 41.85 43.22 46.55
Pivot Point 40.44 40.44 39.74 40.42 40.44
Support 1 (S1) 37.55 38.26 36.14 37.51 34.17
Support 2 (S2) 34.73 36.91 34.71 33.70
Support 3 (S3) 31.84 34.73 33.22
Support 4 (S4) 31.80